Atea Pharmaceuticals
AVIR
#7432
Rank
$0.29 B
Marketcap
$3.50
Share price
1.74%
Change (1 day)
20.69%
Change (1 year)

Earnings for Atea Pharmaceuticals (AVIR)

Earnings in 2024 (TTM): -$0.18 Billion USD

According to Atea Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$0.14 Billion USD a decrease over its 2022 earnings that were of -$0.12 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atea Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.18 Billion29.65%
2023 -$0.14 Billion12.92%
2022 -$0.12 Billion-186.22%
2021 $0.13 B-1366.01%
2020 -$10.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.13 Billion-28.49%๐Ÿ‡บ๐Ÿ‡ธ USA